| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |